Echinococcosis: Causes, Transmission, and Control PDF

Document Details

EndorsedOrangeTree

Uploaded by EndorsedOrangeTree

Baghdad College of Medicine

Prof. Ameer kadhim Hussein

Tags

echinococcosis parasitic disease tapeworm public health

Summary

This document provides an overview of echinococcosis, a parasitic disease caused by tapeworms of the genus Echinococcus. It covers the different forms, including cystic and alveolar echinococcosis, and explores their epidemiology, transmission, and the importance of preventive and control measures. The document also explains methods of prevention and control, including avoidance and appropriate hygiene practices.

Full Transcript

By Prof. Ameer kadhim Hussein. M.B.Ch.B. FICMS (Community Medicine). Objectives  Describe and discuss the epidemiology, mode of transmission and preventive and control measures of Echinococcus granulosus. Describe and discuss the epidemiology, mode of transm...

By Prof. Ameer kadhim Hussein. M.B.Ch.B. FICMS (Community Medicine). Objectives  Describe and discuss the epidemiology, mode of transmission and preventive and control measures of Echinococcus granulosus. Describe and discuss the epidemiology, mode of transmission and preventive and control measures of E. multilocularis. Introduction Human echinococcosis is a zoonotic disease (a disease that is  transmitted to humans from animals) that is caused by parasites, namely tapeworms of the genus Echinococcus. Echinococcosis occurs in 4 forms: Cystic echinococcosis, also known as hydatid disease or hydatidosis, caused by infection with Echinococcus granulosus. Alveolar echinococcosis, caused by infection with E. multilocularis. Two forms of neotropical echinococcosis: polycystic caused by infection with E. vogeli; and unicystic caused by E. oligarthrus. The two most important forms, which are of medical and public health relevance in humans, are cystic echinococcosis (CE) and alveolar echinococcosis (AE).   Ehinococcosis due to Echinococcus granulosis (Cystic echinococcosis or cystic hydatid disease) Echinococcus granulosus   Echinococcus granulosus Identification It is larval stage of the tape worm Echinococcus granulosus.  It is the most common Echinococcus cause hydatid disease. Hydatid cysts enlarge slowly and required several years for development. The cyst range from (1-15 cm) in diameter but may be larger. Infections may be asymptomatic until cysts cause noticeable mass effect. Signs and symptoms vary according to cyst location, size, type and numbers. Echinococcus granulosus  Infectious agent: Echinococcus granulosus, a small tapeworm of dogs and other canids. Reservoir: The domestic dog and other canids which are definitive hosts for echinococcus granulosus which may harbor thousands of adult tapeworms in their intestines without sign of infection. Intermediate hosts include sheep, goats, pigs, horses and other animals. Humans also regard as intermediate host. Incubation period: 12 months to years depending on number and location of cysts and how rapidly they grow. Echinococcus granulosus Period of communicability:  Not directly transmitted from person or from one intermediate host to another. Infected dogs begin to pass eggs (5-7) weeks after infection. Most canine infections resolve spontaneously by 6 months however some adult worms may survive up to 2-3 years. Dogs may become infected repeatedly. Susceptibility: Children who are more likely to have close contact with infected dogs and less likely to have adequate hygienic habits so have more risk of infection. Mode of transmission: Human infection often take place directly with hand to mouth transfer of eggs after association with infected dogs or indirectly through contaminated food, water, soil or fomites. In some instances flies have dispersed eggs after feeding on infected feces. Life cycle of Echioncoccus granulosus  Cyst layers and contents  Epidemiology  E granulosus is a cosmopolitan parasite, and endemic regions exist in each continent. Considerable public health problems occur in many areas, including countries of Central America and South America, Western and Southern/Southeastern Europe, the Middle East and North Africa, some sub-Saharan countries, Russia and adjacent countries, and China. Annual incidence rates of diagnosed human cases per 100,000 inhabitants vary widely, from less than 1 case per 100,000 to high levels. Epidemiology In endemic regions, human incidence rates for cystic echinococcosis can reach greater than 50 per 100 000 person-years, and prevalence levels as high as 5%–10% may occur in parts of Argentina, Peru, East Africa, Central Asia and China. Cystic echinococcosis causes not only illness but also productivity losses in human and agricultural animal population, and it can have large societal impacts on endemic areas. Mortality/Morbidity Cystic echinococcosisis rarely fatal. Occasionally, deaths occur because of anaphylactic shock or cardiac tamponade in heart echinococcosis. Rare locations of the cyst (muscle, bone, brain, orbit) can cause dramatic and disabling symptoms (blindness, paralysis). Race, Sex and Age Race  No racial predilection exists. Sex In some endemic countries, females are affected more than males because their lifestyle habits and practices bring them into contact with the parasite. Age Individuals of all ages are affected. In some endemic countries, children have higher infection rates because they are most likely to play with dogs. Signs and symptoms  Human infection with E. granulosus leads to the development of one or more hydatid cysts located most often in the liver and lungs, and less frequently in the bones, kidneys, spleen, muscles and central nervous system. The asymptomatic incubation period of the disease can last many years until hydatid cysts grow to an extent that triggers clinical signs. Abdominal pain, nausea and vomiting are commonly seen when hydatids occur in the liver. Signs and symptoms  If the lung is affected, clinical signs include chronic cough, chest pain and shortness of breath. Other signs depend on the location of the hydatid cysts and the pressure exerted on the surrounding tissues. Non-specific signs include anorexia, weight loss and weakness. Case scenario  A 32-year-old woman was admitted to hospital complaining of right upper quadrant and epigastrium abdominal pain, and nausea. On routine physical examination an abdominal mass was discovered on the right upper quadrant. Liver tests were normal. Magnetic resonance imaging of the abdomen revealed a low-density cystic mass (Hydatid cyst). Case scenario  A cystectomy was performed. Hydatid sand containing a protoscolex of Echinococcus granulosus was seen on microscopical examination. Specific antiparasitic treatment was given and after two months the patient is asymptomatic. Methods of control a. Preventive measures:  1. Avoid ingestion of raw vegetables and water that may have been contaminated with feces of infected dogs. Application of hygiene practices such as hand washing and washing of fruits and vegetables. Educate those at high risk to avoid exposure to dog feces and possibly infected dogs. 2.Interrupt transmission from intermediate to definitive hosts by preventing access of dogs to potentially contaminated and uncooked viscera. Disposal of viscera should be by incineration or by deep burial. 3. Periodically treat high risk dogs and all dogs in high risk area. 4. Field and laboratory personnel must observe strict safety precautions to avoid ingestion of tapeworm eggs. Control patient, contacts and immediate environment  1. Report to local health authority. 2. Isolation, concurrent disinfection, Quarantine and immunization of contacts : Not applicable. 3. Investigation of contacts and source of infection: Examine families for suspected cysts by using ultrasound, chest x-ray and other imaging techniques. Check dogs in and around houses for infection. Determine beliefs, practices and behaviors increase risk of infection. Control patient, contacts and immediate environment Specific treatment:  must be based on WHO classification of liver cysts usually surgical intervention is a common treatment. Other cysts types treated by percutaneous techniques such as PAIR ( Puncture, Aspiration, Injection, re-aspiration). Treatment with mebendazole and albendazole has proved successful and may be preferred treatment in many cases. If primary cyst ruptures praziquentel and Protoscolicidal agent reduce risk of secondary cysts. Other cyst types may not need surgical, percutaneous or medical intervention and can follow for long time by (wait and watch). Prognosis Prognosis is generally good and depends on the cyst location. For instance, neither surgery nor medical therapy is generally effective for bone, especially spinal echinococcosis. Surgery to treat cardiac cysts can be risky, and there is very little experience with the use of albendazole in this site. Sometimes after removal of a cyst, one or more new cysts may develop at a different site. A hypothesis for this is that the growth of some cysts may be inhibited by the presence of the cyst that has been removed.  Echinococcosis due to Echinococcus multilocularis (Alveolar echinococcosis) Echinococcus multilocularis  Echinococcus multilocularis  Echinococcus multilocularis Identification:  A highly invasive destructive disease caused by the larval stage of echinococcus multilocularis. Lesions usually found in the liver but because their growth is not restricted by a thick laminated cyst wall they may expand to periphery to produce solid tumor like masses. Metastases can result in secondary cysts and larval growth in other organs. Clinical manifestations depend on the size and location of cysts but are often confused with hepatic carcinoma and cirrhosis. The disease is often fatal although spontaneous cure and calcification has been observed. Diagnosis is often based on histopathology. Sero-diagnosis using purified E. multilocularis antigen is highly sensitive and specific. Echinococcus multilocularis Staging and classification system recently proposed by WHO named PNM is based on: a. Hepatic location of the parasite (P). b. Extra – hepatic involvement of neighboring organs (N). c. Metastases (M). Infectious agent: Ehinococcus multilocularis. Occurrence: Distribution is limited to areas of the Northern Hemisphere (China, Turkey, Canada, Central Europe, Russia …etc). The disease is usually diagnosed in adults. Life Cycle of E. multilocularis The life cycle is basically the same  of E. granulosus except there are different definitive and intermediate hosts. Echinococcus multilocularis Reservoir:  adult tape worms are largely restricted to wild animals such as foxes and E. multilocularis is commonly maintained in nature of fox- rodent cycles. Dogs and cats can be sources of human infection if hunting wild intermediate hosts such as rodents. Mode of transmission: Ingestion of eggs passed in the feces of canidae and felidae that have fed on infected rodents. Fecally soiled dog hair, and environmental fomites also serve as vehicles of infection. Incubation period, period of communicability, Susceptibility and methods of control: as for E. granulosus. Signs and symptoms  Alveolar echinococcosis is characterized by an asymptomatic incubation period of 5–15 years and the slow development of a primary tumour-like lesion which is usually located in the liver. Clinical signs include weight loss, abdominal pain, general malaise and signs of hepatic failure. Larval metastases may spread either to organs adjacent to the liver (for example, the spleen) or distant locations (such as the lungs, or the brain) following dissemination of the parasite via the blood and lymphatic system. If left untreated, alveolar echinococcosis is progressive and fatal. Echinococcus multilocularis  Radical surgical excision is less often successful and must be followed by chemotherapy. Mebendazole or albendazole use for a limited period after surgery or long term for inoperable patients which may prevent progression of the disease. Pre-surgical chemotherapy is indicated in rare cases.  Echinococcosis due to E. Vogeli and E. Oligarthrus (polycystic and unicystic echinococcosis) Echinococcosis due to E. Vogeli and E. Oligarthrus  This disease occurs in the liver, lungs and other viscera. Symptom vary depending on cyst size and location. This species is distinguished by its rostellar hooks. This species is unique in that the germinal membrane proliferate externally to form new cysts and internally to form septae that divide the cavity into numerous microcysts. Brood capsules containing many protocolices develop in the microcysts. The causal agents are E. vogeli and E.oligarthrus occur in Central and South America. Immuno-diagnosis using purified antigen of E. Vogeli does not always allow differentiation from alveolar echinococcosis. Albendazole has been used for chemotherapy. Summary  Human echinococcosis is a parasitic disease caused by  tapeworms of the genus Echinococcus.  The 2 most important forms of the disease in humans are cystic echinococcosis (hydatidosis) and alveolar echinococcosis.  Humans are infected through ingestion of parasite eggs in contaminated food, water or soil, or through direct contact with animal hosts.  Echinococcosis is often expensive and complicated to treat, and may require extensive surgery and/or prolonged drug therapy. Summary   Prevention programmes involve deworming of dogs, improved food inspection and slaughterhouse hygiene, and public education campaigns; vaccination of lambs is currently being evaluated as an additional intervention.  More than 1 million people are affected with echinococcosis at any one time.     

Use Quizgecko on...
Browser
Browser